Jul 17, 2026 05:02AM
Jul 13, 2026 08:03AM
Jul 2, 2026 03:20AM
Jun 29, 2026 09:44AM
Jun 24, 2026 09:42AM
Jun 11, 2026 05:11AM
Jun 1, 2026 04:42AM Madrigal Pharmaceuticals (MDGL) Reiterated at Market Outperform by Citizens
May 13, 2026 06:16AM
May 6, 2026 07:08AM
May 5, 2026 08:03AM
May 5, 2026 08:01AM
Apr 14, 2026 09:47AM
Apr 13, 2026 05:52AM
Apr 1, 2026 12:38PM Wolfe Research comments on Madrigal Pharmaceuticals (MDGL) M&A optimism 'makes strategic sense' for buyers
Mar 31, 2026 09:50AM
Mar 20, 2026 08:15AM
Feb 23, 2026 06:37AM
Feb 19, 2026 01:49PM
Feb 19, 2026 07:07AM
Feb 11, 2026 05:01AM
Feb 4, 2026 06:49AM B.Riley Reiterates Buy Rating on Madrigal Pharmaceuticals (MDGL)
Jan 20, 2026 04:38AM
Jan 14, 2026 12:45AM
Jan 12, 2026 09:32AM
Jan 6, 2026 05:33AM
Dec 19, 2025 08:28AM
Dec 8, 2025 07:32AM
Nov 21, 2025 01:28PM Madrigal Pharmaceuticals (MDGL) PT Raised to $620 at H.C. Wainwright
Nov 20, 2025 04:02AM
Nov 19, 2025 06:05AM
Nov 13, 2025 05:33AM
Nov 10, 2025 08:02AM
Nov 5, 2025 05:23AM
Nov 5, 2025 04:59AM
Nov 4, 2025 04:08PM Cantor Fitzgerald Upgrades Madrigal Pharmaceuticals (MDGL) to Overweight, 'clarity on 2026 growth and no major near-term headwinds for the stock'
Nov 4, 2025 07:04AM
Nov 3, 2025 06:28AM
Oct 16, 2025 04:19AM
Oct 15, 2025 06:19AM
Oct 14, 2025 04:03PM
Oct 10, 2025 05:29AM
Sep 24, 2025 08:50AM UBS Reiterates Buy Rating on Madrigal Pharmaceuticals (MDGL) as Management Confident in MASH Market Opportunity
Sep 12, 2025 06:23AM
Sep 4, 2025 06:14AM
Aug 26, 2025 08:38AM
Aug 22, 2025 07:17AM
Aug 20, 2025 08:54AM
Aug 20, 2025 04:16AM
Aug 19, 2025 04:05PM Madrigal gets EU approval for first MASH treatment Rezdiffra
Aug 18, 2025 10:59AM

432,296 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All